Clinical trials
alpha 1-Antitrypsin Deficiency trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 3 |
| Baxalta now part of Shire | 2 |
| Grifols Therapeutics LLC | 2 |
| Sanofi | 2 |
| AIRNA Corporation | 1 |
| Arrowhead Pharmaceuticals | 1 |
| Beam Therapeutics Inc. | 1 |
| Inhibrx Biosciences, Inc | 1 |
| Intellia Therapeutics | 1 |
| Korro Bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| alpha 1-Antitrypsin Deficiency | 16 |
| Emphysema | 3 |
| Lung Diseases | 2 |
| Pulmonary Emphysema | 2 |
| Congenital Abnormalities | 1 |
| Genetic Diseases, Inborn | 1 |
| Infant, Newborn, Diseases | 1 |
| Liver Diseases | 1 |
| Pathologic Processes | 1 |
| Pathological Conditions, Signs and Symptoms | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.